Home Roche pays $8.3bn for drug's potential
 

Keywords :   


Roche pays $8.3bn for drug's potential

2014-08-26 16:02:00| Biotech - Topix.net

Swiss pharmaceutical company Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash in order to get hold of a promising respiratory drug, in the latest multibillion-dollar deal in a consolidating pharmaceutical and biotechnology sector.

Tags: potential pays drugs roche

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
17.05Is China's bubble tea bubble about to burst?
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Business locked in expensive AI 'arms race'
17.05Is the move to electric cars running out of power?
17.05Pornhub partners with UK child abuse fighting charity
16.05CFTC charges Agridime and its co-founders with a fraudulent cattle scheme
16.05Baleage: Advantageous for first cutting hay
More »